Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis

NCT06041919 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Decision was made by the sponsor not to progress to Stage 2

Conditions

Rifampicin Susceptible Pulmonary Tuberculosis

Interventions

DRUG: RESP301
DRUG: HRZE

Sponsor

Thirty Respiratory Limited